The cerebellar and thalamic degeneration in Fukuyama-type congenital muscular dystrophy

S Kumada1, K Tsuchiya, M Takahashi

  • 1Department of Clinical Neuropathology, Tokyo Metropolitan Institute for Neuroscience, Japan.

Acta Neuropathologica
|February 15, 2000
PubMed

Insights

Fukuyama-type congenital muscular dystrophy (FCMD) autopsy revealed unusual brain abnormalities. Long-term survival highlighted latent neurodegeneration in the cerebellum and thalamus, alongside congenital malformations.

Area of Science:

  • Neuropathology
  • Neuroscience
  • Genetics

Background:

  • Fukuyama-type congenital muscular dystrophy (FCMD) is a severe genetic disorder.
  • Characterized by muscle weakness and intellectual disability from infancy.
  • Autopsy cases provide crucial insights into disease progression.

Observation:

  • A 26-year-old male with FCMD presented with severe psychomotor retardation and muscular dystrophy.
  • Neuropathological examination revealed extensive cerebral and cerebellar cortical dysplasia.
  • Degeneration was noted in the cerebellar efferent pathway and lateral thalamic nucleus.

Findings:

  • The primary finding was congenital malformations characteristic of FCMD.
  • Unusual neuropathological findings included degeneration of the dentate nucleus, superior cerebellar peduncle, red nucleus, and lateral thalamic nucleus.
  • These observations suggest that prolonged survival may unmask latent neurodegeneration.

Implications:

  • Long survival in FCMD patients can reveal previously unrecognized neurodegenerative processes.
  • System degeneration in the cerebellum and thalamus warrants careful pathological evaluation in FCMD.
  • Understanding these neuropathological aspects is vital for comprehensive FCMD management and research.

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...